Human tissue-engineered products.

Exciting developments are taking place that present a complex challenge for regulations and standards.

[1]  W. Konertz,et al.  Clinical experience with autologous endothelial cell-seeded polytetrafluoroethylene coronary artery bypass grafts. , 2000, The Journal of thoracic and cardiovascular surgery.

[2]  Matthew J Dalby,et al.  Increasing fibroblast response to materials using nanotopography: morphological and genetic measurements of cell response to 13-nm-high polymer demixed islands. , 2002, Experimental cell research.

[3]  Takehisa Matsuda,et al.  Human endothelial progenitor cell-seeded hybrid graft: proliferative and antithrombogenic potentials in vitro and fabrication processing. , 2003, Tissue engineering.

[4]  David L Kaplan,et al.  Silk-based biomaterials. , 2003, Biomaterials.

[5]  Yan Li,et al.  Autologous cell transplantation and cardiac tissue engineering: potential applications in heart failure. , 2003, Biorheology.

[6]  Ulrich M. Gassner.  Tissue Engineering im Normendschungel , 2001 .

[7]  S. Meaume,et al.  Cost-effectiveness of wound management in France: pressure ulcers and venous leg ulcers. , 2002, Journal of wound care.

[8]  P. Ducheyne,et al.  In vivo evaluation of a bioactive scaffold for bone tissue engineering. , 2002, Journal of biomedical materials research.

[9]  M. Zheng.  Cell-Based Tissue Engineering , 2002 .

[10]  M. B. Claase,et al.  Porous PEOT/PBT scaffolds for bone tissue engineering: preparation, characterization, and in vitro bone marrow cell culturing. , 2002, Journal of biomedical materials research. Part A.

[11]  B. Byrne,et al.  Myoblast cell grafting into heart muscle: cellular biology and potential applications. , 1999, Annual review of physiology.

[12]  C. Verfaillie.  Adult stem cells: assessing the case for pluripotency. , 2002, Trends in cell biology.

[13]  Johnny Huard,et al.  Gene therapy and tissue engineering based on muscle-derived stem cells. , 2002, Current opinion in molecular therapeutics.

[14]  M. Augustin,et al.  Chronic leg ulcers : cost evaluation of two treatment strategies , 1999 .

[15]  L. Griffith,et al.  Tissue Engineering--Current Challenges and Expanding Opportunities , 2002, Science.

[16]  R. Langer,et al.  Biodegradable, Elastic Shape-Memory Polymers for Potential Biomedical Applications , 2002, Science.

[17]  S. C. Huang,et al.  Multilineage Potential of Homozygous Stem Cells Derived from Metaphase II Oocytes , 2003, Stem cells.

[18]  I. Weissman,et al.  Wnt proteins are lipid-modified and can act as stem cell growth factors , 2003, Nature.

[19]  Magdalena Fossum,et al.  ISOLATION AND IN VITRO CULTIVATION OF HUMAN UROTHELIAL CELLS FROM BLADDER WASHINGS OF ADULT PATIENTS AND CHILDREN , 2003, Scandinavian journal of plastic and reconstructive surgery and hand surgery.

[20]  G. Keilhoff,et al.  Reconstruction of peripheral nerves using acellular nerve grafts with implanted cultured Schwann cells , 2002, Microsurgery.

[21]  R M Nerem,et al.  Vascular tissue engineering. , 2001, Annual review of biomedical engineering.

[22]  Ulf Persson,et al.  Resource use and costs in a Swedish cohort of patients with Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.

[23]  R. Martin,et al.  A guide to biological skin substitutes. , 2002, British journal of plastic surgery.

[24]  J. Posnett,et al.  Cost-effectiveness modeling of Dermagraft for the treatment of diabetic foot ulcers in the french context. , 2000, Diabetes & metabolism.

[25]  Heinrich Planck,et al.  Rat Schwann cells in bioresorbable nerve guides to promote and accelerate axonal regeneration , 2003, Brain Research.

[26]  G. Naughton,et al.  From Lab Bench to Market , 2002 .

[27]  D. F. Williams,et al.  The Williams dictionary of biomaterials , 1999 .

[28]  A. Mikos,et al.  Adhesion and migration of marrow-derived osteoblasts on injectable in situ crosslinkable poly(propylene fumarate-co-ethylene glycol)-based hydrogels with a covalently linked RGDS peptide. , 2003, Journal of biomedical materials research. Part A.

[29]  P. Wernet,et al.  [Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction]. , 2001, Deutsche medizinische Wochenschrift.

[30]  I. Weissman,et al.  A role for Wnt signalling in self-renewal of haematopoietic stem cells , 2003, Nature.

[31]  M J Lysaght,et al.  The growth of tissue engineering. , 2001, Tissue engineering.

[32]  J F Elliott,et al.  Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. , 2001, Diabetes.

[33]  P. Menasché.  Cell therapy of heart failure. , 2002, Comptes rendus biologies.

[34]  E. Sim,et al.  Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. , 2003, The Annals of thoracic surgery.

[35]  F. Djouad,et al.  Regenerative medicine through mesenchymal stem cells for bone and cartilage repair. , 2002, Current opinion in investigational drugs.

[36]  P. Zilla,et al.  Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience. , 1999, Surgery.

[37]  M. Heidaran,et al.  Molecular Signaling in Bioengineered Tissue Microenvironments , 2002, Annals of the New York Academy of Sciences.

[38]  P. Couvreur,et al.  Long-Circulating PEGylated Polycyanoacrylate Nanoparticles as New Drug Carrier for Brain Delivery , 2001, Pharmaceutical Research.

[39]  Jeffrey A Hubbell,et al.  Photopolymerized hyaluronic acid-based hydrogels and interpenetrating networks. , 2003, Biomaterials.

[40]  W M Miller,et al.  Dynamic model of ex vivo granulocytic kinetics to examine the effects of oxygen tension, pH, and interleukin-3. , 2000, Experimental hematology.

[41]  W. Mark Saltzman,et al.  Building drug delivery into tissue engineering design , 2002, Nature Reviews Drug Discovery.

[42]  K. Shakesheff,et al.  Growth factor release from tissue engineering scaffolds , 2001, The Journal of pharmacy and pharmacology.

[43]  R. Löbenberg,et al.  Interaction of Poly(butylcyanoacrylate) Nanoparticles with the Blood-Brain Barrier in vivo and in vitro , 2001, Journal of drug targeting.

[44]  A. Perets,et al.  Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. , 2003, Journal of biomedical materials research. Part A.

[45]  Bartolozzi,et al.  Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow‐repopulating ability together with the expansion of committed progenitors , 2000, British journal of haematology.

[46]  Constance M. Chen,et al.  New directions in bioabsorbable technology. , 2002, Orthopedics.

[47]  D. Williams,et al.  Macrophage subpopulation differentiation by stimulation with biomaterials. , 1997, Journal of biomedical materials research.

[48]  J. Kreuter,et al.  Nanoparticulate systems for brain delivery of drugs. , 2001 .

[49]  D. W. Jackson,et al.  THE ARTICULAR CARTILAGE REPAIR DILEMMA Symptomatic Articular Cartilage Degeneration , 2001 .

[50]  Michael J Lysaght,et al.  Private sector development of stem cell technology and therapeutic cloning. , 2003, Tissue engineering.

[51]  C. Zandonella.  Tissue engineering: The beat goes on , 2003, Nature.

[52]  Eugene Khor,et al.  Implantable applications of chitin and chitosan. , 2003, Biomaterials.

[53]  B. Fleischmann,et al.  Cellular Cardiomyoplasty Improves Survival After Myocardial Injury , 2002, Circulation.

[54]  R. Bareille,et al.  Cultured differentiated human urothelial cells in the biomaterials field. , 2000, Biomaterials.

[55]  Antonios G Mikos,et al.  Biomaterials and Scaffolds in Reparative Medicine , 2002, Annals of the New York Academy of Sciences.

[56]  H. Greisler,et al.  Biomaterials in the development and future of vascular grafts. , 2003, Journal of vascular surgery.

[57]  P. Zilla,et al.  Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. , 2001, The Annals of thoracic surgery.

[58]  A. Burls,et al.  Effectiveness of autologous chondrocyte transplantation for hyaline cartilage defects in knees: a rapid and systematic review. , 2001, Health technology assessment.

[59]  Joseph P Vacanti,et al.  Dynamic rotational seeding and cell culture system for vascular tube formation. , 2003, Tissue engineering.

[60]  Bernd Westphal,et al.  Autologous bone-marrow stem-cell transplantation for myocardial regeneration , 2003, The Lancet.

[61]  Anthony Atala,et al.  De novo reconstitution of a functional mammalian urinary bladder by tissue engineering , 1999, Nature Biotechnology.

[62]  V. Falanga,et al.  An economic assessment of Apligraf® (Graftskin) for the treatment of hard‐to‐heal venous leg ulcers , 2000, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[63]  Matthew J Dalby,et al.  Nucleus alignment and cell signaling in fibroblasts: response to a micro-grooved topography. , 2003, Experimental cell research.

[64]  S. Parente.  Estimating the economic cost offsets of using Dermagraft-TC as an alternative to cadaver allograft in the treatment of graftable burns. , 1997, The Journal of burn care & rehabilitation.

[65]  Sibylle Gaisser,et al.  Human Tissue Engineered Products - Today's Markets and Future Prospects , 2003 .

[66]  L W Rue,et al.  Wound closure and outcome in extensively burned patients treated with cultured autologous keratinocytes. , 1992, The Journal of trauma.

[67]  U A Stock,et al.  Tissue engineering of heart valves -- current aspects. , 2002, The Thoracic and cardiovascular surgeon.

[68]  P. Thomsen,et al.  In vitro study of monocyte viability during the initial adhesion to albumin- and fibrinogen-coated surfaces. , 2001, Biomaterials.

[69]  H. Matthew,et al.  Hybrid, Composite, and Complex Biomaterials , 2002, Annals of the New York Academy of Sciences.

[70]  Roland Hetzer,et al.  Tissue-engineering bioreactors: a new combined cell-seeding and perfusion system for vascular tissue engineering. , 2002, Tissue engineering.

[71]  Robert Langer,et al.  Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation , 1999, The Lancet.

[72]  Kytai Truong Nguyen,et al.  Photopolymerizable hydrogels for tissue engineering applications. , 2002, Biomaterials.

[73]  E. Ryan,et al.  Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. , 2000, The New England journal of medicine.

[74]  Catherine M. Verfaillie,et al.  Pluripotency of mesenchymal stem cells derived from adult marrow , 2002, Nature.

[75]  D. Gore.  Outcome and cost analysis for outpatient skin grafting. , 1997, The Journal of trauma.

[76]  R. Satava.  Disruptive visions: Moral and ethical challenges from advanced technology and issues for the new generation of surgeons , 2002 .

[77]  M S Chapekar,et al.  Tissue engineering: challenges and opportunities. , 2000, Journal of biomedical materials research.

[78]  Larry L Hench,et al.  Third-Generation Biomedical Materials , 2002, Science.

[79]  G. Vogel.  Studies Cast Doubt on Plasticity of Adult Cells , 2002, Science.

[80]  M. Toner,et al.  Storage and Translational Issues in Reparative Medicine , 2002, Annals of the New York Academy of Sciences.

[81]  A Curtis,et al.  Tissue engineering: the biophysical background. , 2001, Physics in medicine and biology.

[82]  Vladimir Mironov,et al.  Organ printing: computer-aided jet-based 3D tissue engineering. , 2003, Trends in biotechnology.

[83]  Laura E Niklason,et al.  Human arteries engineered in vitro , 2003, EMBO reports.

[84]  Jan Feijen,et al.  Biodegradable elastomeric scaffolds for soft tissue engineering. , 2003, Journal of controlled release : official journal of the Controlled Release Society.